Albemarle Corp

ALB: XNYS (USA)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
$846.00ZgvkdlGwmmkqp

Albemarle Earnings: Plummeting Prices Pause Expansion Plans

Albemarle's second-quarter results reflected the lithium price decline as companywide adjusted EBITDA plummeted 70% versus the prior-year quarter. Management announced further capital expenditure reductions and cost-cutting initiatives in response to lower lithium prices. Most notably, the company signaled it would place phase two of the Kemerton lithium hydroxide processing facility into care and maintenance and stop work on phase three. Management also signaled it will reduce its unit production costs to boost profits in the wake of lower lithium prices and cut capital expenditure further in 2025 and beyond.

Sponsor Center